Newton Biocapital is a venture capital firm that focuses on financing biotech and life science projects.
Business Model:
Revenue: $0
Employees: 0-0
Address:
City:
State:
Zip:
Country:
Newton Biocapital is a venture capital firm that focuses on financing biotech and life science projects.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
2/2021 | DeuterOncology | Seed Round | - |
5/2021 | EditForce | Venture Round | 0 |
10/2018 | Sequana Medical | Series D | 0 |
6/2023 | Santero Therapeutics | Series A | 0 |
2/2018 | Synergia Medical | Series A | 10M |
11/2020 | Perseus Proteomics | Venture Round | 0 |
7/2020 | J-Pharma | Series D | 0 |
3/2019 | EditForce | Series B | 0 |
9/2017 | Dim3 | Venture Round | 4.7M |
1/2023 | DeuterOncology | Series A | 0 |
10/2018 | Acticor Biotech | Series B | 0 |
6/2021 | NeuVasQ | Series A | 0 |
11/2019 | Acticor Biotech | Series B | 0 |
11/2020 | AbolerIS Pharma | Seed Round | 0 |
1/2023 | AdipoPharma | Series A | - |
5/2018 | ChromaCure | Venture Round | 19.6M |
6/2023 | Santero Therapeutics | Series A | 0 |
1/2023 | AdipoPharma | Series A | - |
1/2023 | DeuterOncology | Series A | 0 |
6/2021 | NeuVasQ | Series A | 0 |
5/2021 | EditForce | Venture Round | 0 |
2/2021 | DeuterOncology | Seed Round | - |
11/2020 | Perseus Proteomics | Venture Round | 0 |
11/2020 | AbolerIS Pharma | Seed Round | 0 |
7/2020 | J-Pharma | Series D | 0 |
11/2019 | Acticor Biotech | Series B | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|